VO2Max Level of Convicted Students at Special Prisons for Child Development Institution (LPKA) Class II Bengkulu DOI Creative Commons
Yahya Eko Nopiyanto, Diah Ayu Aguspa Dita, Dian Pujianto

et al.

Kinestetik Jurnal Ilmiah Pendidikan Jasmani, Journal Year: 2023, Volume and Issue: 7(4), P. 2015 - 2024

Published: Dec. 31, 2023

The level of VO2 max has significance in relation to both physical activity and health. Nevertheless, it should be noted that there been a lack VO2Max tests conducted on convicted children at LPKA Class II Bengkulu. Therefore, this study aims determine the among This used quantitative descriptive approach examine sample 91 between aged 14 19 years. test uses multi-stage fitness test. analysis research data involved utilization percentages, which were employed compare category tables. study's findings indicated proportion 1.1% exhibited levels falling within lower group, while substantial majority 98.90% showed significantly category. Based results, was concluded Bengkulu fell extremely bad range. study, supervisors devise execute coaching regimen enhance children.

Language: Английский

Artificial intelligence and obesity management: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 DOI Creative Commons
Harold Bays, Angela Fitch, Suzanne Cuda

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 6, P. 100065 - 100065

Published: April 20, 2023

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) provides clinicians an overview of Artificial Intelligence, focused on the management patients with obesity.

Language: Английский

Citations

68

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024 DOI Creative Commons
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki

et al.

Journal of clinical lipidology, Journal Year: 2024, Volume and Issue: 18(3), P. e320 - e350

Published: April 24, 2024

BACKGROUNDThis joint expert review by the Obesity Medicine Association (OMA) and National Lipid (NLA) provides clinicians an overview of pathophysiologic clinical considerations regarding obesity, dyslipidemia, cardiovascular disease (CVD) risk.METHODSThis is based upon scientific evidence, perspectives authors, peer OMA NLA leadership.RESULTSAmong individuals with adipose tissue may store over 50% total body free cholesterol. Triglycerides represent up to 99% lipid species in tissue. The potential for expansion accounts greatest weight variance among most individuals, percent fat ranging from less than 5% 60%. While population studies suggest a modest increase blood low-density lipoprotein cholesterol (LDL-C) levels excess adiposity, adiposopathic dyslipidemia pattern often described adiposity includes elevated triglycerides, reduced high density (HDL-C), increased non-HDL-C, apolipoprotein B, LDL particle concentration, small, dense particles.CONCLUSIONSObesity increases CVD risk, at least partially due promotion adiposopathic, atherogenic profile. also worsens other cardiometabolic risk factors. Among patients interventions that reduce improve outcomes are generally associated improved levels. Given improvement LDL-C reduction overweight or early treat both (LDL-C and/or non-HDL-C) priorities reducing CVD. This risk. leadership. particles.

Language: Английский

Citations

27

Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024 DOI Creative Commons
Harold Bays, Carol F. Kirkpatrick, Kevin C. Maki

et al.

Obesity Pillars, Journal Year: 2024, Volume and Issue: 10, P. 100108 - 100108

Published: March 12, 2024

This joint expert review by the Obesity Medicine Association (OMA) and National Lipid (NLA) provides clinicians an overview of pathophysiologic clinical considerations regarding obesity, dyslipidemia, cardiovascular disease (CVD) risk. is based upon scientific evidence, perspectives authors, peer OMA NLA leadership. Among individuals with adipose tissue may store over 50% total body free cholesterol. Triglycerides represent up to 99% lipid species in tissue. The potential for expansion accounts greatest weight variance among most individuals, percent fat ranging from less than 5% 60%. While population studies suggest a modest increase blood low-density lipoprotein cholesterol (LDL-C) levels excess adiposity, adiposopathic dyslipidemia pattern often described adiposity includes elevated triglycerides, reduced high density (HDL-C), increased non-HDL-C, apolipoprotein B, LDL particle concentration, small, dense particles. increases CVD risk, at least partially due promotion adiposopathic, atherogenic profile. also worsens other cardiometabolic risk factors. patients interventions that reduce improve outcomes are generally associated improved levels. Given improvement LDL-C reduction overweight or early treat both (LDL-C and/or non-HDL-C) priorities reducing CVD.

Language: Английский

Citations

19

Obesity, diabetes mellitus, and cardiometabolic risk: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023 DOI Creative Commons
Harold Bays,

Shagun Bindlish,

Tiffany Lowe Clayton

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 5, P. 100056 - 100056

Published: Jan. 28, 2023

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians an overview of type 2 diabetes mellitus (T2DM), obesity-related cardiometabolic risk factor.

Language: Английский

Citations

32

Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023 DOI Creative Commons

Tiffany Lowe Clayton,

Angela Fitch, Harold Bays

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 8, P. 100083 - 100083

Published: Aug. 7, 2023

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) provides an overview of the mechanisms and treatment obesity hypertension.

Language: Английский

Citations

18

Obesity, thrombosis, venous disease, lymphatic disease, and lipedema: An obesity medicine association (OMA) clinical practice statement (CPS) 2023 DOI Creative Commons

Shagun Bindlish,

Jennifer Ng,

Wissam Ghusn

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 8, P. 100092 - 100092

Published: Oct. 19, 2023

This Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) is intended to provide clinicians with an overview on obesity, thrombosis, venous disease, lymphatic and lipedema.

Language: Английский

Citations

13

Comprehensive care for patients with obesity: An Obesity Medicine Association Position Statement DOI Creative Commons
Angela Fitch,

Lydia Alexander,

C. Brown

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 7, P. 100070 - 100070

Published: May 18, 2023

Language: Английский

Citations

11

Racialized body dissatisfaction in Black women: development of the Black feminist model of body image DOI Creative Commons
Rachel L. Boutté,

Ashley Johnson,

Neha J. Goel

et al.

Journal of Eating Disorders, Journal Year: 2025, Volume and Issue: 13(1)

Published: Feb. 24, 2025

Body image has predominantly been examined among young White women. As a result, the guiding theories in this area of study are based on implicit assumptions that population's experience is normative. These include thinness as ideal body type and lack consideration shape, skin tone, hair texture image. research examining Black women limited by using theoretical constructs do not fully capture lived experiences population. The purpose was to investigate role racialized beauty aesthetic women's Eight focus groups were conducted with 30 aged 18–29 Mass Index (BMI) ≥ 25-kg/m2. Focus used semi-structured interview guide assess race, ideals, pressures meet social costs benefits obtaining ideals. We constructivist grounded theory approach develop conceptual model. This method's steps initial, focused, coding. Results indicated standardization Eurocentric standards resulted stigmatization devaluation appearance. Participants described being stigmatized basis their appearance feeling devalued due prevalence negative stereotypes about behavior. Experiences gendered racism dissatisfaction. coped these engaging shifting behaviors reduce stigmatizing marks or rejecting normative Whiteness. Both coping methods came benefits; participants expressed they felt no-win situation, which had adverse health consequences. findings development Feminist Model Image. Consideration context intersectional marginalized identities highlights how perpetuate work implies efforts improve must seriously consider dissatisfaction mental physical health. mainly studied women, understood meeting thin. However, definition did experiences. In study, we 8 thirty explore racial identity influenced found often criticized mistreated attributes such texture, shape. some took actions modify blend better helped them school environments but led like authentic. Others chose embrace differences at disadvantage environments. All reported having navigate issues daily influence

Language: Английский

Citations

0

Obesity Management in Primary Care: A Joint Clinical Perspective and Expert Review from the Obesity Medicine Association (OMA) and the American College of Osteopathic Family Physicians (ACOFP) - 2025 DOI Creative Commons
N. J. Pennings, Catherine Varney,

Stephanie L. Hines

et al.

Obesity Pillars, Journal Year: 2025, Volume and Issue: unknown, P. 100172 - 100172

Published: March 1, 2025

This collaboration from the Obesity Medicine Association (OMA) and American College of Osteopathic Family Physicians (ACOFP) examines obesity management a primary care perspective. joint perspective is based upon scientific evidence, clinical experience authors, peer review by OMA ACOFP leadership. The goal to identify answer sentinel questions about perspective, utilizing evidence-based publications, guided expert experience. disease that contributes both biomechanical complications most common cardiometabolic abnormalities encountered in care. Barriers impede optimal patients with include failure recognize as disease, lack accurate diagnosis, insufficient access treatment resources, inadequate training, time, adequate reimbursement adverse impact bias, stigma, discrimination. physicians are often first line healthcare setting. affords early intervention opportunities prevent and/or treat overweight obesity. Patient enhanced when clinicians risks benefits anti-obesity medications bariatric procedures, well long-term follow-up. Practical tools regarding 4 pillars nutrition therapy, physical activity, behavior modification, medical interventions (anti-obesity surgery) may assist improve health lives living

Language: Английский

Citations

0

Universal Prior Authorization Template for glucagon like peptide-1 based anti-obesity medications: An Obesity Medicine Association proposal DOI Creative Commons
Harold Bays, C. Brown, Angela Fitch

et al.

Obesity Pillars, Journal Year: 2023, Volume and Issue: 8, P. 100079 - 100079

Published: Aug. 2, 2023

Language: Английский

Citations

3